AMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluation of the glycolytic response of in vitro cell models to metabolic stress.
Oxygen Consumption measurements have become a key functional readout of cell metabolism and mitochondrial function, providing important insights into the cell function and role of perturbed metabolism in disease progression. These measurements are easily performed in standard microplates using AMSBIO's MitoXpress® Xtra Oxygen Consumption Assay.
While measurements of basal Oxygen Consumption alone are very informative, additional information can be gleaned from assessing parameters such as basal respiration, maximal respiration, spare respiratory capacity as well as ATP-coupled, non-ATP coupled and non-respiratory oxygen consumption. These parameters are now conveniently measurable on conventional fluorescence plate readers with the new MitoXpress® Stress Test kit from AMSBIO. Designed for use in combination with MitoXpress® Xtra Oxygen Consumption Assay, the MitoXpress® Stress Test contains all metabolic modulators required to characterise the main parameters of mitochondrial function in live cells. Compounds are provided pre-weighed for convenient handling and reproducibility. A detailed protocol is provided to facilitate easy and reproducible data generation and interpretation.
Glycolysis is a critical ATP generating pathway in eukaryotic cells and plays a central role in numerous pathologies including cancer, diabetes, autoimmune, and neurodegenerative diseases. The ability to conveniently characterize the glycolytic profile of in vitro cell models used in these disease areas and to determine how specific stress interventions (e.g. nutrient deprivation, hypoxia, drug treatment) impact that profile is therefore of considerable interest.
The new pH-Xtra Stress Test from AMSBIO has been designed for use as a companion kit to their pH-Xtra Glycolysis Assay and contains all the additional components necessary for the evaluation of the glycolytic response of in vitro cell models to metabolic stress. It contains a measurement buffer tablet and glucose to allow the convenient adjustment of glucose availability, 2-deoxyglucose as a glycolysis inhibitor, and oligomycin, an inhibitor of respiration driven ATP-generation to trigger maximum glycolytic activity.
For further information on these new products please visit http://www.amsbio.com/metabolism-oxygen-consumption-and-glycolysis-assays.aspx or contact AMSBIO on 44-1235-828200/ +1-617-945-5033 / email@example.com.
Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products, and services for research and development in the medical, nutrition, cosmetics, and energy industries. AMSBIO can draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion, and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.
Like this article? Click here to subscribe to free newsletters from Lab Manager